MILLER RICHARD A MD

Average Profitability
5.51%
Insider Buys Quantity
29
Insider Buys Sum
$3.68M
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of MILLER RICHARD A MD

According to the SEC Form 4 filings, MILLER RICHARD A MD, being in a position of

  1. President and CEO at Corvus Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 577634 shares for $1,000,000, and sold 0 shares,
    over all time since 2016-05-12, has bought 1091060 shares for $3.68M, and sold 0 shares.

The largest purchase of all time was on 2024-05-06 and amounted to 577634 shares of Corvus Pharmaceuticals, Inc. for $1,000,000.

Biography of MILLER RICHARD A MD

No biography is available at this moment.

2024-05-06PurchaseCorvus Pharmaceuticals, Inc.
CRVS
President and CEO
577,634
1.0676%
$1.73$1,000,000+87.96%
2022-12-14PurchaseCorvus Pharmaceuticals, Inc.
CRVS
President and CEO
10,000
0.021%
$0.78$7,812+78.13%
2022-12-13PurchaseCorvus Pharmaceuticals, Inc.
CRVS
President and CEO
50,000
0.1031%
$0.74$37,015+84.18%
2022-06-24PurchaseCorvus Pharmaceuticals, Inc.
CRVS
President and CEO
5,000
0.0123%
$1.00$4,985+4.6%
2022-06-02PurchaseCorvus Pharmaceuticals, Inc.
CRVS
President and CEO
890
0.002%
$1.01$899-7.89%
2022-03-31PurchaseCorvus Pharmaceuticals, Inc.
CRVS
President and CEO
15,000
0.0321%
$1.64$24,534-44.51%
2022-03-15PurchaseCorvus Pharmaceuticals, Inc.
CRVS
President and CEO
5,000
0.0117%
$1.59$7,950-36.44%
2021-08-20PurchaseCorvus Pharmaceuticals, Inc.
CRVS
President and CEO
10,000
0.0229%
$1.93$19,254-5.76%
2021-05-04PurchaseCorvus Pharmaceuticals, Inc.
CRVS
President and CEO
35,714
0.0833%
$2.80$99,999-13.38%
2021-02-17PurchaseCorvus Pharmaceuticals, Inc.
CRVS
President and CEO
100,000
0.2817%
$3.50$350,000-23.75%
2019-11-13PurchaseCorvus Pharmaceuticals, Inc.
CRVS
President and CEO
14,736
0.0514%
$3.00$44,240+33.11%
2019-11-12PurchaseCorvus Pharmaceuticals, Inc.
CRVS
President and CEO
272
0.0009%
$2.90$789+33.68%
2019-08-07PurchaseCorvus Pharmaceuticals, Inc.
CRVS
President and CEO
2,500
0.0085%
$3.54$8,850-0.57%
2019-08-06PurchaseCorvus Pharmaceuticals, Inc.
CRVS
President and CEO
5,000
0.0171%
$3.58$17,875-1.4%
2019-06-14PurchaseCorvus Pharmaceuticals, Inc.
CRVS
President and CEO
11,657
0.04%
$3.40$39,666+4.73%
2019-06-13PurchaseCorvus Pharmaceuticals, Inc.
CRVS
President and CEO
343
0.0011%
$3.52$1,207-2.88%
2019-06-11PurchaseCorvus Pharmaceuticals, Inc.
CRVS
President and CEO
6,000
0.0217%
$3.67$22,020+2.02%
2019-06-07PurchaseCorvus Pharmaceuticals, Inc.
CRVS
President and CEO
9,212
0.031%
$3.37$31,019+4.4%
2018-12-27PurchaseCorvus Pharmaceuticals, Inc.
CRVS
President and CEO
20,000
0.0685%
$3.29$65,884+19.91%
2018-12-20PurchaseCorvus Pharmaceuticals, Inc.
CRVS
President and CEO
10,000
0.0349%
$4.39$43,950-8.84%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.